(Q35106016)

6 August 2017

Pharmacodynamics of imipenem in combination with β-lactamase inhibitor MK7655 in a murine thigh model (English)

1 reference

6 August 2017

1 reference

6

Johan W Mouton

1 reference

6 August 2017

Eleftheria Mavridou

1

1 reference

6 August 2017

Ria J B Melchers

2

1 reference

6 August 2017

Anita C H A M van Mil

3

1 reference

6 August 2017

E Mangin

4

1 reference

6 August 2017

Mary R Motyl

5

1 reference

6 August 2017

language of work or name

English

0 references

publication date

17 November 2014

1 reference

Antimicrobial Agents and Chemotherapy

6 August 2017

1 reference

6 August 2017

59

1 reference

6 August 2017

2

1 reference

6 August 2017

790-795

1 reference

The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4335905

Carbapenemases: the versatile beta-lactamases

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4335905

Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4335905

Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4335905

Amoxycillin clavulanate: an assessment after 15 years of clinical application

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4335905

The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4335905

Combination beta-lactam and beta-lactamase-inhibitor products: antimicrobial activity and efficiency of enzyme inhibition.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4335905

Emergence of four cases of KPC-2 and KPC-3-carrying Klebsiella pneumoniae introduced to Switzerland, 2009-10.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4335905

Antimicrobial Resistance: Pharmacokinetics‐Pharmacodynamics of Antimicrobial Therapy: It’s Not Just for Mice Anymore

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4335905

The history and background of Augmentin

16 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25403667

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.03706-14

1 reference

6 August 2017

1 reference

6 August 2017

1 reference